A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Sadick Research Group, New York

Renstar Medical Research, Ocala

Tennessee Clinical Research Center, Nashville

Dermatology Specialists Research, New Albany

Dermatology Specialists Research, Louisville

Dawes Fretzin Dermatology Group, Indianapolis

Suzanne Bruce and Associates, Katy

Austin Institute for Clinical Research, Pflugerville

Alliance Dermatology and Mohs Center, Phoenix

Dermatology Research Associates, Los Angeles

University of California, Irvine - Dermatology Clinical Research Center, Irvine

Oregon Dermatology and Research Center, Portland

Metro Boston Clinical Partners, Brighton

Psoriasis Treatment Center of Central New Jersey, East Windsor